 | After Euphoria, a Traffic Jam on the Multi-Billion Dollar Kilo-Highway |
June 12, 2026 at 12:23 pm
|
 | Novo Nordisk: The tide has begun to turn |
May 06, 2026 at 05:10 pm
|
| Novo Nordisk: Slipping expectations frustrate investors again and again |
February 12, 2026 at 09:08 am
|
| Novo Nordisk: What is Novo really up against? |
February 05, 2026 at 08:58 pm
|
 | Novo Nordisk exposed to a price war over obesity treatments |
February 04, 2026 at 10:38 pm
|
| Novo Nordisk: Disappointing the markets is becoming a habit |
February 04, 2026 at 04:15 pm
|
 | Novo Nordisk plunges as its 2026 outlook rattles investors |
February 04, 2026 at 02:10 pm
|
| Novo Nordisk steady amid Lilly Retatrutide risks |
December 12, 2025 at 07:14 pm
|
 | No plane sailing for Novo Nordisk |
November 25, 2025 at 04:20 pm
|
 | Novo Nordisk valuation hit by obesity fears |
November 25, 2025 at 12:42 pm
|
| Novo Nordisk faces US drug price cuts but gains wider obesity coverage |
November 10, 2025 at 04:52 pm
|
| Novo Nordisk faces earnings miss and guidance cut amid obesity drug Competition |
November 05, 2025 at 06:16 pm
|
| Novo Nordisk: Exhibiting aggression, Novo gatecrashes Pfizer-Metsera's party |
October 31, 2025 at 05:18 pm
|
 | All hands on deck at Novo Nordisk! |
September 10, 2025 at 01:04 pm
|
 | Novo Nordisk: Wegovy - beyond diabetes and obesity |
August 19, 2025 at 11:17 am
|
| Novo Nordisk falters once again |
July 29, 2025 at 04:39 pm
|
 | How did Novo Nordisk lose the US market? |
July 02, 2025 at 01:11 pm
|
 | The Parvus fund enters Novo Nordisk's capital |
June 10, 2025 at 03:06 pm
|
 | Wegovy on the rise amongst American teens; between effectiveness and reluctance |
June 04, 2025 at 12:01 pm
|
 | Novo Nordisk CEO ousted as battle against obesity intensifies |
May 16, 2025 at 04:40 pm
|
 | MarketScreener roundup: abysmal trade deficit and massive share buybacks in the US; Novo Nordisk's valuation on a diet |
May 07, 2025 at 01:06 pm
|
 | Novo Nordisk is weak, but that's enough |
May 07, 2025 at 11:27 am
|
 | Novo Nordisk: Penalized by Eli Lilly's success |
April 22, 2025 at 03:06 pm
|
 | Novo Nordisk under threat from first anti-obesity generics |
March 10, 2025 at 05:37 pm
|
 | Cagrisema sends Novo Nordisk to the mat |
December 20, 2024 at 02:20 pm
|
Choose MarketScreener 
